Disease & disorder

doxorubicin induced cardiomyopathy

MONDO:0023006

Clinical trials7
Recruiting1
Drug concepts studied4
Synonyms0

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

doxorubicin induced cardiomyopathy

Wikidata Q55790164 ↗
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

7 shown
Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced CardiotoxicityNCT06427226 · 2024-10-31
RECRUITING
Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer PatientsNCT07370506 · 2026-02-01
NOT_YET_RECRUITING
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer PatientsNCT06092606 · 2023-04-04
UNKNOWN
The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer PatientsNCT07668076 · 2022-11-15
COMPLETED
99mTc-rhAnnexin V-128 Imaging and Cardiotoxicity in Patients With Early Breast CancerNCT02677714 · 2016-11-02
TERMINATED
Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via ChemotherapyNCT02796365 · 2016-06-01
COMPLETED
Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer PatientsNCT03000036 · 2012-07-01
COMPLETED

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.